Vol. 8, Issue 5 (2019)
Development of specification for substance 7-azepan-1-il-1-ethil-6-ftor-3- (4-phenyl-1, 3-tiazol-2-il) - Quinoline-4 (1h)-one
Spyrydonova NV, Silin AV, Lebedynets VA, Zavada OA and Kalinenko OS
The paper presents the results of the development of specifications for a new first-synthesized chemical compound exhibiting antibacterial activity and positioned as a perspective drug substance. According to the recommendations of the European Pharmacopoeia quality control procedures have been developed for standardization the substance of 7-azepan-1-yl-1-ethyl-6-fluoro-3-(4-phenyl-1,3-thiazol-2-yl))-quinoline-4(1H)-one - a modified derivative of the fluoroquinolone series.
How to cite this article:
Spyrydonova NV, Silin AV, Lebedynets VA, Zavada OA and Kalinenko OS. . The Pharma Innovation Journal. 2019; 8(5): 54-56.